European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Heidelberg, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts
DKFZ Deutsches Krebsforschungszentrum
DKFZ Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts
Deutsches Krebsforschungszentrum ( DKFZ)
Deutsches Krebsforschungszentrum Heidelberg
Deutsches Krebsforschungszentrum Stiftung DES Öffe
Deutsches Krebsforschungszentrumstiftung DES Öffen
Dkfz

Register

Lei
96760090F5YU3KTUQ312

Address

Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Financials

History

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

6 Mar 2024
Patent: USE of Bmmf1 REP Protein AS Biomarker for Colorectal Cancer
21 Feb 2024
Wordmark: “AI Life Delta“
9 Jan 2024
Wordmark: “ONE NCT“
1 Jan 2024 as Deutsches Krebsforschungszentrum (DKFZ)
Public funding (€497,250): Objective Measurement of Surgical Quality through the Development of a Data-Based Value Creation Network (SurgicalAIHubGermany), Subproject: New Methods for Intraoperative …
Year 2023 in Fk
14 German state fundings (€7,631,050): German Competence Center Cloud Technologies for Data Management and Processing - en. KCD: Subproject en. KCD-DKFZ at the German Cancer Research Center (DKFZ) …
Year 2023 in Epobase
3 European patent filings: Histone Anti-Cancer Vaccines …
5 Sept 2023
Word figurative mark
Year 2023 in Fts
15 EU fundings (total €5,986,710): 101062042 - Mrdaml - Deciphering the Mechanistic Basis of Minimal Residual Disease and Treatment Resistance in Acute Myeloid Leukemia …
2 Aug 2023
Wordmark: “NCT“
20 Jun 2023
Word figurative mark: “NCT“
31 May 2023 via Apogenix GmbH
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021 · Shareholdings: Apogenix Treuhand GmbH, German Cancer Research Center (DKFZ), dievini …
Year 2022 in Euipotm
4 trademark filings (1 wordmark, 3 word figurative marks): GHGA …
Year 2022 in Epobase
20 European patent filings: REP Protein AS Protein Antigen for USE in Diagnostic Assays …
Year 2022 in Fts
23 EU fundings (total €10.4M): 101096667 - Melcaya - Novel Health Care Strategies for Melanoma in Children, Adolescents and Young Adults …
Year 2022 in Fk
8 German state fundings (€22.9M): GDICall: German Investment Genomics Data Infrastructure (GDI-DE) - GDI-DE-DKFZ …
15 Jul 2022 via Apogenix GmbH
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020 · Shareholdings: Apogenix Treuhand GmbH, German Cancer Research Center (DKFZ), dievini …
Year 2021 in Epobase
18 European patent filings: Proteomics-Based Stratification of Acute Myeloid Leukaemia …
Year 2021 in Fk
12 German state fundings (€7,042,694): Preparatory phase of the implementation of the expansion of the National Center for Tumor Diseases (NCT) …
Year 2021 in Fts
10 EU fundings (total €6,536,615): 894568 - Twscc - Trafficking of WNT Signaling Components in Cancer …
7 Jul 2021
Figurative mark
Year 2021 in Hor
5 EU fundings (€162,806): Deciphering immune evasion of Acute Myeloid Leukemia …
2 Mar 2021
Utility patent: Combination therapy for lymphoma
9 Feb 2021 via Apogenix GmbH
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Shareholdings: Apogenix Treuhand GmbH, German Cancer Research Center (DKFZ), dievini Hopp BioTech holding GmbH & Co. KG
7 Jan 2021
Wordmark: “EpiTrace“
Year 2020 in Epobase
31 European patent filings: CONTROL DEVICE FOR CONTROLLING AT LEAST ONE COLLIMATOR …
Year 2020 in Fk
15 German state fundings (€8,501,066): Verbund - AI: Artificial intelligence for the innovative sustainable radiation protection of patients in interventional radiological applications …
Year 2020 in Fts
9 EU fundings (total €2,500,098): 956285 - Vagabond - Validation of Actionable Genomic Aberrations in a Paediatric Oncology Network for Doctorate Students …
Year 2020 in Hor
11 EU fundings (€1,500,000): DNA Breaks Shape Neural Genome Heterogeneity …
Year 2020 in Euipotm
4 trademark filings (3 wordmarks, 1 figurative mark): DKTK, EpiTrace, HI-TRON Mainz …
2 Apr 2020
Patent: Method for the characterization of modifications caused by the use of designer nucleases
5 Feb 2020
Patent: Method for creating an image of an object OFF measurement data
Year 2019 in Epobase
41 European patent filings: Biomarker Panel for Diagnosing Colorectal Cancer …
Year 2019 in Fk
22 German state fundings (€13.2M): DATABLIC carrot and stick? Data sharing policies for public (German) research sponsors. TP 1+2 Ethical and Social Aspects …
Year 2019 in Hor
14 EU fundings (€0.00): HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and …
1 Oct 2019
Word figurative mark: “Nationales Krebspräventionszentrum dkfz. DEUTSCHES KREBSFORSCHUNGSZENTRUM IN DER HELMHOLTZ-GEMEINSCHAFT Deutsche Krebshilfe HELFEN, FORSCHEN, INFORMIEREN …
1 Oct 2019
Word figurative mark: “National Cancer Prevention Center“
Year 2019 in Fts
16 EU fundings (total €14.4M): 788937 - Ctcfstablegenome - Ctcf Control of Genome Stability in Ageing …
8 Aug 2019
Patent: Use of Bmmf REP Protein AS Biomarker for Colon Carcinoma
Year 2018 in Epobase
37 European patent filings: METHOD OF SCANNING A SAMPLE WITH A LIGHT BEAM FOCUSED BY A MICROSCOPE OBJECTIVE LENS AND SCANNING LIGHT MICROSCOPE …
Year 2018 in Hor
13 EU fundings (€522,339): European Advanced infraStructure for Innovative Genomics …
Year 2018 in Fk
5 German state fundings (€2,909,628): microRNA regulatory signaling pathways involved in neural migration …
Year 2018 in Fts
8 EU fundings (total €6,259,649): 764698 - Quantii - Quantitative T Cell Immunology and Immunotherapy …
1 Aug 2018
Patent: Prediction methods of mortality Due to treatment with erythropoiesis Stimulating agents
Year 2017 in Epobase
33 European patent filings: METHOD OF SCANNING A SAMPLE WITH A LIGHT BEAM FOCUSED BY A MICROSCOPE OBJECTIVE LENS AND SCANNING LIGHT MICROSCOPE …
Year 2017 in Fk
16 German state fundings (€8,403,037): The Cognitive Radiological Assistant (CoRA) - Sub-Projects: Modeling the Patient Journey for Structured Assessment …
Year 2017 in Dp
4 patent filings: Cancer Therapy with One Parvovirus H-1 Combined with An Anti-PD-1 Antibody or An Anti-PD-L-1 Antibody …
Year 2017 in Fts
5 EU fundings (total €7,013,772): 742039 - Redox Relays - Detecting, Understanding and Exploiting Intracellular Redox Signaling Relays …
Year 2017 in Hor
7 EU fundings (€498,433): A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology …
18 Aug 2017
Wordmark: “HI-TRON“
Year 2016 in Epobase
22 European patent filings: MODIFIED PARVOVIRUS USEFUL FOR GENE SILENCING …
Year 2016 in Fts
6 EU fundings (total €7,333,832): 702642 - Hoxa9 Degradome - Deciphering the Machinery Involved in Stability of the Transcription Factor Hoxa9. …
Year 2016 in Fk
24 German state fundings (€10.3M): PANC-STRAT: An integrative approach to personalized treatment of pancreatic cancer patients - TP 2, TP 4 and TP 7 …
Year 2016 in Hor
6 EU fundings (€1,508,710): Deciphering the machinery involved in stability of the transcription factor HOXA9. …
15 Sept 2016
Patent: DNA methylation Based method for classifying tumor species
23 Dec 2015
Patent: Procedure for predicting a personalized ESA dose IN the treatment of anemia
Year 2015 in Fk
17 German state fundings (€17.1M): Development of a cost-effective vaccine against cervical cancer - a prophylactic approach, subproject: Development of purified antigens and evaluation of …
Year 2015 in Epobase
4 European patent filings: Modulators of the Function of the Core Domain of Annexins, and Uses Thereof in Autoimmune and/or Cancer Therapy …
Year 2015 in Hor
10 EU fundings (€92,619): RNA EDITING IN HEALTH AND DISEASE …
Year 2015 in Fts
11 EU fundings (total €31.8M): 633784 - B-Cast - Breast Cancer Stratification: Understanding the Determinants of Risk and Prognosis of Molecular Subtypes …
16 Apr 2015
Utility patent: Micropress for high-throughput detection of mechanical cell properties
29 Jan 2015
Patent: Cancer therapy with a parvovirus in combination with a BCL-2 inhibitor
Year 2014 in Epobase
4 European patent filings: Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy …
Year 2014 in Fk
15 German state fundings (€8,519,281): Tumor-specific gene changes: new potential target structures of tumor therapy …
1 Sept 2014 as DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG STIFTUNG
EU funding (€161,969): Identifying and Characterising Transmembrane Transporters of Tryptophan and Kynurenine in Normal and Cancerous Brain Tissue
18 Aug 2014
Wordmark: “DataThereHouse“
1 Apr 2014 as DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG STIFTUNG
EU funding (€100,000): Support of a European Research Career: Mechanisms of Mismatch Repair Inactivation and Identification of Genes Suppressing Mutations
Year 2013 in Fk
12 German state fundings (€6,124,307): Internet communication on tobacco products and e-cigarettes …
Year 2013 in Fts
11 EU fundings (total €39.2M): Iact …
29 Oct 2013
Patent: Micro-RNAs Modulating the Effect of Glucocorticoid Signaling
Year 2012 in Dp
4 patent filings (3 patents, 1 utility patent): Method and device for imaging a structure marked with a fluorescent dye in a sample …
19 Dec 2012
Patent: Cancer Therapy with a Parvovirus Combined with Chemotherapy
Year 2012 in Fts
13 EU fundings (total €41.4M): Gene Therapy for X-Linked Chronic Granulomatous Disease (CGD) …
Year 2012 in Fk
21 German state fundings (€14.7M): Energy-selective X-ray imaging for safety technology, subproject: Quantitative X-ray imaging of complex objects with energy-selective detectors …
Year 2012 in Euipotm
4 trademark filings (2 wordmarks, 2 word figurative marks): Deutsches Krebsforschungszentrum, German Cancer Research Center …
Year 2011 in Fts
9 EU fundings (total €30.7M): Development of a Therapeutic HPV Vaccine VIA Target Epitope Identification by Mass Spectrometry …
3 Nov 2011
Patent: Diagnostic procedures to predict a patient's response to viral chemotherapy or viral radiation therapy
29 Aug 2011
Word figurative mark: “dkfz.“
1 Jun 2011 as Deutsches Krebsforschungszentrum (DKFZ)
Public funding (€1,701,202): AGENET - Multi-scale analysis of aging - From molecule to tissue - Subproject A (DKFZ)
10 May 2011
Wordmark: “NCT“
18 Apr 2011
Patent: Gpr177 as Target and Marker in Tumors
1 Jan 2011 as Deutsches Krebsforschungszentrum (DKFZ)
Public funding (€1,612,484): Axonal regeneration after spinal cord injuries: The role of local protein translation
1 Jan 2011 as Deutsches Krebsforschungszentrum (DKFZ)
Public funding (€1,775,166): ESTHER-II, TP1 'Central cohort study and intervention study', TP2a 'Epidemiology, course and prevention of multimorbidity and frailty in old age'
9 Dec 2010
Patent: Oncolytic virotherapy for the prevention of tumor recurrence
9 Dec 2010
Patent: Cancer therapy methods Based on the simultaneous administration of a parvovirus and a cytokine
1 Dec 2010
Patent: Diagnostic methods for the prognosis of a brain tumor
Year 2010 in Fk
12 German state fundings (€13.2M): International Cancer Genome Consortium (ICGC): Determination of molecular menchanisms in malignant lymphoma (ICGC-MMML-Seq), work packages C2, 7b and 8a …
Year 2010 in Fts
8 EU fundings (total €37.4M): Asset …
Year 2010 in Epobase
4 European patent filings: Parvovirus Having a CpG-Enriched Genome Useful for Cancer Therapy …
Year 2009 in Fts
13 EU fundings (total €4,604,760): Mast-Cell-Functions …
Year 2009 in Epobase
5 European patent filings: USE of Bacteria for the Sensing and Killing of Cancer Cells …
Year 2009 in Fk
21 German state fundings (€13.5M): EpiSys - Experimental and theoretical methods for the analysis of the dynamics of epigenetic 'gene silencing' in living cells - Subproject 1 …
29 Jul 2009
Patent: Cancer therapy with a parvovirus in combination with chemotherapy
9 Jul 2009
Patent: Parvovirus cancer therapy and combination with chemotherapy
1 Jul 2009
Patent: Parvovirus mit CpG-angereichertem Genom zur Krebstherapie
Year 2008 in Fts
5 EU fundings (total €3,056,199): Data Analysis for Integr Project AcuteTox …
Year 2008 in Fk
28 German state fundings (€34.7M): LungSys: Systems Biology of Lung Cancer: Identification of Risks in Erythropoietin Treatment and Prognosis of Prevention Strategies (DKFZ Subprojects, Coordinator) …
15 Oct 2008
Patent: Albumin Conjugates Containing a Glucuronic Linker
14 Apr 2008
Wordmark: “dkfz“
19 Oct 2007
Patent: Rspondins AS Modulators of Angiogenesis and Vasculogenesis
Year 2007 in Fk
9 German state fundings (€8,813,775): Colon chip: Development and optimization of a biochip for diagnosis of colorectal cancer, location DKFZ …
23 May 2007
Patent: A Pharmaceutical Preparation Containing Palladium Complex Compounds
Year 2006 in Fk
10 German state fundings (€5,816,665): HepatoSys Network Regeneration, Subprojects: B1, B5, B6, B8, C2 …
14 Jun 2006
Patent: Identification of JAK/Stat Pathway Modulating Genes by Genome Wide Rnai Screening
10 Feb 2006
Patent: Use of a Gadolinium Chelate for Labeling Cells
12 Oct 2005
Patent: Peptide Useful for Diagnosis and Therapy of Tumors
Year 2005 in Fk
9 German state fundings (€7,165,632): Standardization for regenerative medicine, DKFZ, Heidelberg, subproject: Molecular differentiation features for the determination of cardiomyocyte and hepatocyte …
15 Jun 2005
Patent: Identification of JAK/Stat Pathway Modulating Genes by Genome Wide RNAi Screening
19 Apr 2005
Patent: Peptides Useful for Diagnosis and Therapy of Tumors
7 Oct 2004
Patent: Improved FC fusion proteins
1 Feb 2004 in Fts
EU funding: WEB Accessible MR Decision Support System for Brain Tumour Diagnosis and Prognosis, Incorporating in Vivo and EX Vivo Genomic and Metabolimic Data

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Heidelberg, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close